Member Info for Aldebaran

Volume now picking up and price on the rise. As predicted.

Least I am talking about lloyd not like the majority here all yapping on about politics jeez guys get Facebook and give it a rest

Midway through the day and only 20m volume.

Slight drop this morning on low volume, watch the price push on over next few hours and finish at our near days high

From fundamental POV it's market cap to free cashflow ratio which with a reduced share count and increased cashflow could and should see company go on to make alltime highs.

I'll be trading the levels but would be very content if I were a long term investor here as looks in an excellent position for a sustained share price rally.

90p my first target

Dividends reinvested

Company only 30% through a massive share buyback program

Chart absolutely gloriously primed for a big run

Long LONG way to go before prior highs are seen again.

Personally I'm a trader so I'll be selling at next major resistance level which is 90p but can see this going much further in medium term so I'll be in and out

Most likely price will now squeeze up as shorts close and buy orders placed above the breakout zone, which is the neckline from the head and shoulders pattern, is reached. Many people place limit orders at these points.

Really REALLY strong buy signals here, on all timeframes. GL all

Lloyds is looking exceptionally strong now. Reverse head and shoulders pattern complete and price broken out to the upside. Momentum rising. Target 90p

I posted this the other day but all to busy arguing with each other about who is the least worst politicians

https://www.proactiveinvestors.co.uk/companies/news/1071373/lloyds-named-top-pick-as-deutsche-backs-uk-banks-for-next-phase-of-growth-1071373.html

Just share your Facebook accounts and go at it online with each other or better still arrange a meet up and fight to the deaf and let's keep this chat for lloyds only is that to much, too ask.

Anyway on lloyds news did all see Deutsche Bank latest?

Why would their be a raise when we have cash till Q1 next year and coris still to sell plus we have said repeatedly we will partner 6k assets for phase 2.

The company will make a deal for SGC or STS or TNBC on the back of P1B data. Absolutely no need for a raise before a deal is made. P1b data release to us plebs end of year but those in the data room are seeing it already.

Wonder how SGC is performing given healthier patient populations.. that's my guess for the indication avacta deal on. Not optimal but it's the one which is most derisked and will get us what we need for that £XXBn valuation which is 6103 on the clinic.

Why you guys all talk politics and arguing on here that is what Facebook is for.

This is supposed to be a bulletin bored to chat about lloyds

What is more likely from here.

Share price halfing of share price at least doubling?

Because that is the risk reward to think about.

Personally think we wake up to a 7am RNS saying deal done and SP more than doubles on open

Just thinking aloud also even if there is 1bn shares in issue which would be ridiculous and we only achieve a 10bn buyout which is also conservative in the below scenario they that's 10pound per share their or approximate 30x uplift from here.

You can see why retaining 100% ownership of asset outweighs downside of dilution by this. Yet people still harp on about RI's and disaster placing like it's end off the world. What would cut your upside is the company share price gapping open at a 1, 2, or 300% premium to closing price.

Suddenly your 30 bagger is "only" a ten bagger. Still grate but a lot of dollar left on the table which u will kick yourself for giving all the evidence stating you in the face

Deal for STS would transform Avacta overnight but I think theyll do a deal on SGC it would be OK. Neatly packaged up for someone else with ODD designation and an open goal with no SoC and mPFS already doubled. Accelerated approval is almost a certainty for this one it's as risk free as you can get. Anyone taking it forward can be billing £XXXm within 2 years.

Even if Avacta had just £50m upfront for this and royalties it transforms us and allows us to progress STS & TNBC plus get the beast into clinic.

As said before with the beast in clinic avacta price tag goes from £XBn to £XXBn

Patents secured, 6103 in clinic, IND done for other newer pipeline assets and TNBC + STS in P2 woth exceptional P1b results and the whole platform underpinned by over 4 years worth of solid data at that point. It sells and is probably the optimal point to do so.

Even if we sign an inferior deal for one of our assets now (STS, TNBC or SGC) but the money is enough to make 4 CLN payments in cash, get the accounts signed of as a going concern and get the beast into clinic we are laughing.

I don't think we're far away as people think to seeing that RNS landing and transforming us.

Https://www.proactiveinvestors.co.uk/companies/news/1071373/lloyds-named-top-pick-as-deutsche-backs-uk-banks-for-next-phase-of-growth-1071373.html

Lol

Administration. Ok.

What's the IP worth? BP will still be scrambling over that in a nightmare scenario. Not gonna happen though. CC and as have already said they've had people queueing up for smaller deals.

Worst case is get get diluted more than necessary however upside keeps growing so it's not as bad as it sounds.

Maybe we're forced to make some kind of inferior deal on 6k. Also not the end of the world.

Get the beast into clinic and we're absolutely laughing

6103 is a beast as described. also said was how unusual it is for clinical data to be better than in vivo which is unique to precision so avacta are alluding to the pre clinical results which were extraordinary to be bettered in the clinic.

Also said was that exetecan can treat tumours which have been treat with other drugs unsuccessfully as its that powerful.

Yes, avacta are sat on a multi-billion asset. Not only can exetecan be delivered right to the tumour but 6103 is fully modulatable.

She seems relaxed about financing and seems confident of 6103 being in the clinic next year so it's clear as day they'll partner 6k and it has to come soon.

Partnering 6103 is shelved until patents are approved and we have clinical data. Exactly right.

Now, AVA6K is different. I'm expecting partnership announcement here very soon

Heard that time and time again but always follow price and I do just fine.

Also no need to repeatedly bring up avacta on this bored. They will be just fine ya know, curing cancer with drugs worth billions.